Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Case report

Successful administration of cariprazine in a young, severely ill patient with recurrent relapses of schizophrenia and persistent negative symptoms

Bibliographic Data

ID15529236
AuthorsJeļena Vrubļevska (0000-0001-8274-8896, Riga Stradiņš University, corresponding author)
Year2023
Volume14
Pages1134692-1134692
Publication date2023-03-09
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2023.1134692
PMID36970274
OpenAlexW4323668975
LanguageEN
Citations received1
References cited44

The present case report describes a young man diagnosed with schizophrenia and presents a "revolving door" (RD) phenomenon. He was hospitalized in an acute psychiatric clinic three times in 1 year. After each hospitalization, he was discharged with incompletely reduced psychotic symptoms, persistent negative symptoms, low functioning, lack of insight, and adherence. He had an insufficient response to maximally tolerated doses of antipsychotic monotherapy with haloperidol and risperidone. Moreover, his treatment was complicated due to the low accessibility of long-acting injectable atypical antipsychotics (LAI) in the country and his refusal of the only available atypical LAI paliperidone palmitate and refusal to take clozapine. Due to limited alternatives, the decision to administer combinations of antipsychotics was made. Since his diagnosis, he received several combinations of antipsychotics, i.e., haloperidol + quetiapine, risperidone + quetiapine, haloperidol + olanzapine, risperidone + olanzapine, but without sufficient clinical effectiveness. Although combinations of antipsychotics reduced his positive symptoms to some degree, persistent negative symptoms and extrapyramidal side effects were observed. After initiating cariprazine, which was combined with olanzapine, improvement in the patient's positive symptoms, negative symptoms, and overall functioning was detected. The combination of medications mentioned above facilitated the therapeutic alliance, thus providing control over the symptoms and preventing psychiatric hospitalizations

Antipsychotic · Atypical antipsychotic · Clozapine · Dopamine · Extrapyramidal symptoms · Haloperidol · Olanzapine · Psychiatry · Quetiapine · Risperidone · Schizophrenia (object-oriented programming · Epilepsy research and treatment · Medicine · Pathogenesis and Treatment of Hiccups · Psychology · Schizophrenia research and treatment · Internal Medicine · Pediatrics

  • Clinical challenges in the dosing and titration of cariprazine

    Open Access•Čedo Miljević, Čedo D Miljević et al.•Frontiers in Psychiatry•2024

  • Schizophrenia

    Open Access•Jim Van Os, Shitij Kapur•The Lancet•2009

  • The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

    Stanley R Kay, Abraham Fiszbein et al.•Schizophrenia Bulletin•1987

  • Case Report

    Open Access•Māris Taube•Frontiers in Psychiatry•2021

  • Dosing Cariprazine Within and Beyond Clinical Trials

    Open Access•Elmārs Rancāns, Z B Dombi et al.•Frontiers in Psychiatry•2022

  • Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study

    Open Access•Magnus Johan Engen, Anja Vaskinn et al.•Frontiers in Psychiatry•2022

Citations per year0.5
Citation span2024 - 2024 (1)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae